Clinical Trial Update: Regorafenib in Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating regorafenib in metastatic colorectal cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Stivarga (regorafenib)

Snippet

Sponsor: University of Rochester | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-04-06